Long Yuan

发表

Oxidative Cyclization‐Induced Activation of a Phosphoinositide 3‐Kinase Inhibitor for Enhanced Selectivity of Cancer Chemotherapeutics

Edward J Merino, Haizhou Zhu, J. Landero-Figueroa, 2019, ChemMedChem.

Current Advances in the Treatment of BRAF-Mutant Melanoma

Aaron White, Rosalin Mishra, Hima Patel, 2020, Cancers.

Role of Reactive Oxygen Species and Targeted Therapy in Metastatic Melanoma

Rosalin Mishra, Hima Patel, J. Garrett, 2018 .

Activating HER3 mutations in breast cancer

N. Jura, T. Thaker, Rosalin Mishra, 2018, Oncotarget.

BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dependence on Increased Antioxidant SOD2 and Increased Reactive Oxygen Species Levels

Rosalin Mishra, Xin Wei, Zhijun Ma, 2020, Cancers.

Utilization of Reactive Oxygen Species Targeted Therapy to Prolong the Efficacy of BRAF Inhibitors in Melanoma

Edward J Merino, A. L. Kadekaro, Edward J. Merino, 2018, Journal of Cancer.

Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells

B. Liu, Runzhi Zhu, J. Xia, 2014, Molecular medicine reports.

HER3 signaling and targeted therapy in cancer

Rosalin Mishra, Hima Patel, J. Garrett, 2018, Oncology reviews.

Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth

Haizhou Zhu, Aaron White, P. Desai, 2021, International journal of molecular sciences.

HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers

S. Storr, Rosalin Mishra, Hima Patel, 2022, PloS one.